Usefulness Of Homoeopathic medicine in the treatment of Post-stroke hemiplegia

Effectiveness Of Individualised Homoeopathic Medicine As An Adjuvant In The Management Of Post-Stroke Hemiplegia: A Single Arm Prospective Interventional Study - Nil

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/08/072795

Enrollment

Registered

2024-08-20

Start date

Unknown

Completion date

Unknown

Last updated

2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G819- Hemiplegia, unspecified

Interventions

Intervention1: Individualised Homoeopathic Medicine: Administration of Individualised Homoeopathic medicines of any potency as per the need of the case for the treatment of post-stroke hemiplegia for

Eligibility

Inclusion criteria

Inclusion criteria: 1.Hemiplegic patients having a history of stroke/CVA. 2.MRI or CT scan-based evidence of stroke.

Exclusion criteria

Exclusion criteria: 1.Hemiplegia secondary to trauma or tumour. 2.Patients with known meningitis, encephalitis. 3.Patients with known cerebral metastasis, rapidly growing malignant neoplasms, multiple sclerosis, and slow-growing neoplasms ruled out by MRI. 4.Patients with malignant hypertension, uncontrolled hyperlipidaemia and uncontrolled diabetes. 5.Patients with severe manifestations of stroke (NIHSS score more than 20). 6.Pregnant and lactating women.

Design outcomes

Primary

Measure	Time frame
The outcome measurement will be done by assessing reduction in the NIHSS score after administration of individualised homoeopathic medicine.Timepoint: Baseline, 5th month and 10th month of the study.	—

Secondary

Measure	Time frame
NilTimepoint: Nil	—

Countries

India

Contacts

Public ContactDr SGS Chakravarthy

National Homoeopathy Research Institute In Mental Health

sgschakravarthy@gmail.com9908019739

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026